Comment on "MeDIP real-time qPCR of maternal peripheral blood reliably identifies trisomy 21"

Prenatal Diagnosis

Volumn 33, Issue 4, 2013, Pages 403-

  Qin, Han ^a   Bonifacio, Michael ^a   Mcarthur, Steven ^a   Mclennan, Andrew ^b   Boogert, Tom ^b   Bowman, Mark ^a  

^a Genea   (Australia)

^b Sydney Ultrasound for Women   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER;

DNA METHYLATION; FIRST TRIMESTER PREGNANCY; HUMAN; LETTER; MATERNAL BLOOD; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; TRISOMY 21;

DNA; DNA METHYLATION; DOWN SYNDROME; FEMALE; HUMANS; IMMUNOSORBENT TECHNIQUES; PREGNANCY; PRENATAL DIAGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84875647753     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4028     Document Type: Letter

References (3)

1. Tsaliki E, Papageorgiou EA, Spyrou C, et al. MeDIP real-time qPCR of maternal peripheral blood reliably identifies trisomy 21. Prenat Diagn 2012;32:996-1001.
2. Tong YK, Chiu RW, Chan KCA, et al. Technical concerns about immunoprecipitation of methylated fetal DNA for noninvasive trisomy 21 diagnosis. Nat Med 2012;18:1327-8.
3. Papageorgious EA, Karagrigoriou A, Tsaliki E, et al. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med 2011;17:510-3.